Newborn Screening for Pompe Disease: Pennsylvania Experience
Pennsylvania started newborn screening for Pompe disease in February 2016. Between February 2016 and December 2019, 531,139 newborns were screened. Alpha-Glucosidase (GAA) enzyme activity is measured by flow-injection tandem mass spectrometry (FIA/MS/MS) and full sequencing of the GAA gene is perfor...
Main Authors: | Can Ficicioglu, Rebecca C. Ahrens-Nicklas, Joshua Barch, Sanmati R. Cuddapah, Brenda S. DiBoscio, James C. DiPerna, Patricia L. Gordon, Nadene Henderson, Caitlin Menello, Nicole Luongo, Damara Ortiz, Rui Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | International Journal of Neonatal Screening |
Subjects: | |
Online Access: | https://www.mdpi.com/2409-515X/6/4/89 |
Similar Items
-
Hypoglossal neuropathology and respiratory activity in Pompe mice
by: Kun-Ze eLee, et al.
Published: (2011-06-01) -
Establishing Pompe Disease Newborn Screening: The Role of Industry
by: Joan M Keutzer
Published: (2020-07-01) -
Mitochondrial Variants in Pompe Disease: A Comparison between Classic and Non-classic Forms
by: Fatemeh Bahreini, et al.
Published: (2018-06-01) -
Reporting 7 Pompe Patients in Iran
by: Milad Ebrahimi, et al.
Published: (2017-05-01) -
Hypothyroidism in late-onset Pompe disease
by: Joseph Schneider, et al.
Published: (2016-09-01)